All changes for the tissue urinary system (132)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA267
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein
Molecular
kidney
Human
APBB1IP
23.0% Increase Gene Expression Level
DAA289
brain protein 44-like
Molecular
kidney
Human
BRP44L
9.0% Decrease Gene Expression Level
DAA291
chromosome 1 open reading frame 162
Molecular
kidney
Human
C1orf162
37.0% Increase Gene Expression Level
DAA263
claudin 8
Molecular
kidney
Human
CLDN8
17.0% Decrease Gene Expression Level
DAA281
coiled-coil domain containing 3
Molecular
kidney
Human
CCDC3
19.0% Increase Gene Expression Level
DAA275
complement component 1, q subcomponent, C chain
Molecular
kidney
Human
C1QC
27.0% Increase Gene Expression Level
DAA288
complement component 1, r subcomponent
Molecular
kidney
Human
C1R
21.0% Increase Gene Expression Level
DAA265
complement component 1, s subcomponent
Molecular
kidney
Human
C1S
24.0% Increase Gene Expression Level
DAA287
creatine kinase, brain
Molecular
kidney
Human
CKB
10.0% Decrease Gene Expression Level
DAA273
cytoplasmic FMR1 interacting protein 2
Molecular
kidney
Human
CYFIP2
11.0% Decrease Gene Expression Level
DAA1062
Creatinine clearance declines
Physiological
kidney
Human
—
—
DAA272
dedicator of cytokinesis 11
Molecular
kidney
Human
DOCK11
24.0% Increase Gene Expression Level
DAA256
defensin, beta 1
Molecular
kidney
Human
DEFB1
8.0% Decrease Gene Expression Level
DAA258
EF-hand domain family, member D1
Molecular
kidney
Human
EFHD1
9.0% Decrease Gene Expression Level
DAA271
epidermal growth factor (beta-urogastrone)
Molecular
kidney
Human
EGF
25.0% Decrease Gene Expression Level
DAA626
Essential (primary) hypertension and hypertensive renal disease
Pathological
heart, kidney
Human
—
SeriesMorbidity
DAA905
Ability to secrete acid load decreases
Physiological
kidney
Human
—
—
DAA1498
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1
Molecular
kidney
Mouse
Hmgcs1
4.0% Decrease Gene Expression Level
DAA1489
acyl-CoA synthetase medium-chain family member 2
Molecular
kidney
Mouse
Acsm2
5.0% Decrease Gene Expression Level
DAA1485
acylphosphatase 2, muscle type
Molecular
kidney
Mouse
Acyp2
7.0% Decrease Gene Expression Level
DAA1475
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 1
Molecular
kidney
Mouse
Adamts1
7.0% Increase Gene Expression Level
DAA1467
annexin A2
Molecular
kidney
Mouse
Anxa2
8.0% Increase Gene Expression Level
DAA1464
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit b, isoform 1
Molecular
kidney
Mouse
Atp5f1
5.0% Decrease Gene Expression Level
DAA1477
biglycan
Molecular
kidney
Mouse
Bgn
10.0% Increase Gene Expression Level
DAA1458
brevican
Molecular
kidney
Mouse
Bcan
6.0% Decrease Gene Expression Level
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA267 | amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein | Molecular | kidney | Human | APBB1IP | 23.0% Increase Gene Expression Level | |
DAA289 | brain protein 44-like | Molecular | kidney | Human | BRP44L | 9.0% Decrease Gene Expression Level | |
DAA291 | chromosome 1 open reading frame 162 | Molecular | kidney | Human | C1orf162 | 37.0% Increase Gene Expression Level | |
DAA263 | claudin 8 | Molecular | kidney | Human | CLDN8 | 17.0% Decrease Gene Expression Level | |
DAA281 | coiled-coil domain containing 3 | Molecular | kidney | Human | CCDC3 | 19.0% Increase Gene Expression Level | |
DAA275 | complement component 1, q subcomponent, C chain | Molecular | kidney | Human | C1QC | 27.0% Increase Gene Expression Level | |
DAA288 | complement component 1, r subcomponent | Molecular | kidney | Human | C1R | 21.0% Increase Gene Expression Level | |
DAA265 | complement component 1, s subcomponent | Molecular | kidney | Human | C1S | 24.0% Increase Gene Expression Level | |
DAA287 | creatine kinase, brain | Molecular | kidney | Human | CKB | 10.0% Decrease Gene Expression Level | |
DAA273 | cytoplasmic FMR1 interacting protein 2 | Molecular | kidney | Human | CYFIP2 | 11.0% Decrease Gene Expression Level | |
DAA1062 | Creatinine clearance declines | Physiological | kidney | Human | — | — | |
DAA272 | dedicator of cytokinesis 11 | Molecular | kidney | Human | DOCK11 | 24.0% Increase Gene Expression Level | |
DAA256 | defensin, beta 1 | Molecular | kidney | Human | DEFB1 | 8.0% Decrease Gene Expression Level | |
DAA258 | EF-hand domain family, member D1 | Molecular | kidney | Human | EFHD1 | 9.0% Decrease Gene Expression Level | |
DAA271 | epidermal growth factor (beta-urogastrone) | Molecular | kidney | Human | EGF | 25.0% Decrease Gene Expression Level | |
DAA626 | Essential (primary) hypertension and hypertensive renal disease | Pathological | heart, kidney | Human | — | SeriesMorbidity | |
DAA905 | Ability to secrete acid load decreases | Physiological | kidney | Human | — | — | |
DAA1498 | 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 | Molecular | kidney | Mouse | Hmgcs1 | 4.0% Decrease Gene Expression Level | |
DAA1489 | acyl-CoA synthetase medium-chain family member 2 | Molecular | kidney | Mouse | Acsm2 | 5.0% Decrease Gene Expression Level | |
DAA1485 | acylphosphatase 2, muscle type | Molecular | kidney | Mouse | Acyp2 | 7.0% Decrease Gene Expression Level | |
DAA1475 | a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 1 | Molecular | kidney | Mouse | Adamts1 | 7.0% Increase Gene Expression Level | |
DAA1467 | annexin A2 | Molecular | kidney | Mouse | Anxa2 | 8.0% Increase Gene Expression Level | |
DAA1464 | ATP synthase, H+ transporting, mitochondrial F0 complex, subunit b, isoform 1 | Molecular | kidney | Mouse | Atp5f1 | 5.0% Decrease Gene Expression Level | |
DAA1477 | biglycan | Molecular | kidney | Mouse | Bgn | 10.0% Increase Gene Expression Level | |
DAA1458 | brevican | Molecular | kidney | Mouse | Bcan | 6.0% Decrease Gene Expression Level |